Professor of biology at Boston College
Boston College, USA

Prof Thomas Seyfried's work advances the mitochondrial metabolic theory of cancer, arguing that tumors arise from damaged cellular respiration rather than genetic mutation alone, and that this reframing opens the door to non-toxic, metabolism-based therapies.

His research spans ketogenic diets, calorie restriction and fasting protocols, and glutamine-targeting drug therapies, applied across glioblastoma, epilepsy and neurodegenerative lipid storage diseases.

Thomas is the author of the book “Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer” (Wiley, 2012), widely regarded as a landmark contribution to the field.

His contributions have been recognized with the American College of Nutrition Award Lecture and the International Dose Response Society’s Outstanding Career Achievement Award.

Visiting Scholar in the Department of Biology at Boston College
Boston College, USA

Dr Derek Lee is a cancer metabolism researcher whose work bridges the laboratory and the clinic, translating the science of mitochondrial dysfunction into practical strategies for metabolic health. As Chief Science Officer at MitaRev Health and a Visiting Scholar in the Department of Biology at Boston College, he sits at the intersection of fundamental cancer biology and real-world nutrition-based therapeutics.

His research examines the mitochondrial and metabolic mechanisms underlying cancer, aging and neurodegenerative disease, with a particular focus on how disruptions to cellular respiration and gut-microbiome balance connect to broader patterns of metabolic and bone health.

His published work has explored the emerging links between mitochondrial metabolic theory, aging biology and disease prevention.

Research Fellow Role
University of Westminster, UK

Dr Isabella Cooper’s research is reframing how chronic disease is understood and managed. A ketogenic metabolic-endocrine therapy specialist, her doctoral work centered on a cross-over clinical trial, investigating how nutritional ketosis versus suppressed ketosis affects the hormonal growth factors linked to cancers such as breast, ovarian and uterine cancer, with a particular focus on women’s health.

Her research explores how insulin over-signalling damages mitochondria, and how restoring metabolic balance through ketones can help prevent or slow ageing and chronic disease.

Isabella founded the Forever Young Group, a collaborative research network spanning pathology, biochemistry, physiology, hepatology, immunology, neurology, nutrition and genetics, built to tackle pressing challenges in chronic disease.

President
Healthy Longevity Medicine Society, Switzerland

Prof Evelyne Bischof is a physician-scientist working at the intersection of oncology, internal medicine and longevity science, on a mission to bring rigorous, evidence-based healthy longevity medicine out of the lab and into everyday clinical practice. A specialist in internal medicine with a focus on medical oncology, she holds a professorship at Shanghai University of Medicine and Health Sciences, serves as Chief Physician of Internal Medicine at Renji Hospital, Jiaotong University School of Medicine in Shanghai, and is a visiting professor at Tel Aviv University School of Medicine.

She sits on numerous scientific and advisory boards across biotech and longevity organizations, and is a longstanding member of medical societies including the European Federation of Internal Medicine, the World Academy of Medical Sciences and the Swiss Society of Internal Medicine. Evelyne is a frequent speaker at scientific and medical conferences across Asia and Europe on the emerging field of healthspan medicine.

CEO and Co-founder
American Nutrition Association, USA

Corinne has been instrumental in shaping the modern personalized nutrition profession. She helped bring together complementary organizations to create a unified ecosystem that educates practitioners, advances nutrition science, certifies professionals, advocates for evidence-based nutrition, and connects leaders across healthcare. Under her leadership, ANA continues to expand the role of personalized nutrition in preventing, treating, and even reversing complex chronic disease.

As a Certified Nutrition Specialist (CNS), Corinne combines clinical expertise with a deep understanding of the evolving healthcare landscape. Before co-founding ANA, she maintained a private nutrition practice and led nutrition operations for a large compounding pharmacy and wellness center, where she worked closely with patients facing complex health challenges.

Today, Corinne is a recognized leader in personalized nutrition, bringing together clinicians, researchers, educators, policymakers, and industry partners to accelerate the integration of nutrition into mainstream healthcare. Her work reflects her belief that nutrition is foundational to health, longevity, and an effective healthcare system.

Director of Clinical Research
Virta Health, USA

Dr Shaminie J. Athinarayanan, PhD, is Director of Clinical Research at Virta Health and a researcher specializing in metabolic health, type 2 diabetes, obesity, MASLD/MASH, and nutrition-based interventions. She earned her PhD from Purdue University in Medicinal Chemistry and Molecular Pharmacology, with research focused on MASLD/MASH, pharmacogenomics, and the molecular pathways underlying hepatic lipid metabolism and metabolic dysfunction.

With more than a decade of experience across academic and industry research, Dr Athinarayanan leads clinical and real-world evidence studies examining carbohydrate-reduced nutrition, nutritional ketosis, digital healthcare, and pharmacologic therapies, including GLP-1 receptor agonists.

Her research spans diabetes, obesity, cardiovascular risk, chronic kidney disease, and liver disease and has contributed to some of the longest-term published studies evaluating carbohydrate-reduced nutrition and continuous remote care for type 2 diabetes. She has authored numerous peer-reviewed publications and is passionate about translating scientific evidence into practical, scalable approaches to improving metabolic health and reducing the burden of chronic disease.